Personalized attention from experts who care
With conditions such as Parkinson’s disease (PD), tremor, dystonia, and tics, collaboration with a movement disorders specialist is key. Our experts understand your symptoms and can offer a comprehensive approach to optimize your functioning. We see the bigger picture and emphasize a partnership with you and your family.
Support for the Whole Patient and Their Families
Properly managing movement disorders must include both education and support. With informational programs, support groups, psychological care, and caregiver guidance, we’re with you at every step. Our partnership with American Parkinson Disease Association (APDA) provides structured support groups for newly diagnosed PD patients and their families.
The Latest Treatment Options for Movement Disorders
There’s always time for second opinions when considering the treatment best for you. Our customized frameless deep brain stimulation (DBS) technique allows for shorter surgery time and greater patient comfort. We also offer novel non-invasive stimulation for tremor and highly effective Botox injections for dystonia, as well as clinical trial opportunities.
Get a Second Opinion
If you live in the United States outside Greater Los Angeles or are living abroad, our physicians can promptly review your imaging studies and other tests, and provide a recommendation on treatment options.Contact us today to schedule a consultation
Pacific Movement Disorders Center News, Healthy Living and Education
PNI Founders’ Message 2021
Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.
Let’s Talk Parkinson’s Webinar Series: Introduction
The Pacific Movement Disorders Center kicked off its new monthly Let’s Talk Parkinson’s webinar series featuring its specialists and care team providers on various topics in Parkinson’s disease.
New Drug for Lewy Body Dementia Shows Promise
Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.